Dr. Himansu Sekhar Nanda received his Ph. D in Materials Science and Engineering, majoring in Biomaterials from the Research Center for Functional Materials (formerly Polymeric Biomaterials Unit) of National Institute for Materials Science (NIMS), Japan. He holds the background of B-Tech in Biotechnology (from BPUT, Odisha) and M-Tech in Nanotechnology (from IIT Roorkee). He served as a post-doctoral fellow in King Abdullah University of Science and Technology (KAUST), Saudi Arabia and a post-doctoral research fellow at Nanyang Technological University (NTU) Singapore. Currently he is working as an Assistant Professor (tenured) at Indian Institute of Information Technology Design and Manufacturing (IIITDM) Jabalpur, India (an Institute of National Importance, Ministry of Education, Government of India). From August 2022, he is on a long leave from IIITDM Jabalpur and working as a research scientist with the research team of Dr. Ali Khademhosseini at Terasaki Institute for Biomedical Innovation, Los Angles, USA. Dr. Nanda holds several visiting positions: as an adjunct Assistant professor at College of Materials Science and engineering, Beijing University of Chemical Technology and a visiting Scientist at Sate Key Lab of Molecular Engineering of Polymers, Fudan University, China. He has edited a special issue on “Biomaterials: Future of Biomaterials 2021” in journal “Current Opinion in Biomedical Engineering” (Elsevier, 2022 IF 4.16) and "Biodegradable Polymers for Biomedical Applications" in Journal “Frontier in Materials” (Frontiers, 2022 IF 3.5). He is currently a guest editor for special issue on “Intelligent Biomaterials” in Journal “Current Opinion in Biomedical Engineering”. Dr. Nanda is heading Biomedical Engineering and Technology (BET) Laboratory at IIITDM Jabalpur. His current research interests include the design, development, and manufacturing of hydrogel bioinks for 3D bioprinting, non-thrombogenic adhesive polymer coatings for orthopedic bioimplants and new generation polymer scaffolds for regenerative therapies, using FDA approved functional polymers. He is also interested in biomechanics, 3D printing of Orthopedic bioimplants and nanomedicine for angiogenesis.